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Carriers of V115F-TT, SNP1-GG and SNP2-CC genotypes had a 2.84-fold (95 % CI 1.73–4.66), 2.19-fold
(95 % CI 1.09–4.38) and 4.37-fold (95 % CI 1.21–15.08) increased risk for obesity, respectively. Haplotype
analysis showed that GTTC (SNP1/SNP2/V115F/SNP4) had 1.41-fold (95 % CI 1.02–1.95) increased risk
for obesity; whereas, haplotype TTGC had 0.48-fold (95 % CI 0.24–0.96) decreased risk for obesity. Using
the multifactor dimensionality reduction method, the best model including SNP1, SNP2, V115F and SNP4
polymorphisms was identified with a maximum testing accuracy to 59.32 % and a perfect cross-validation
consistency of 10/10 (P = 0.011). Logistic analysis indicated that there was a significant interaction between
SNP1 and V115F associated with obesity. Subjects having both genotypes of SNP1/GG and V115F/TT were
more susceptible to obesity in the Han Chinese population (OR 2.66, 95 %: 1.22–5.80). Genotypes of V115F/
TT, SNP1/GG and SNP2/CC and haplotype GTTC of CIDEA gene were identified as risk factors for obesity
in the Han Chinese population. The interaction between SNP1 and V115F could play a joint role in the
development of obesity.
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53 death-inducing DNA fragmentation factor alpha-like
54 effector A (CIDEA) is a candidate gene for the develop-
55 ment of obesity [3–5].
56 The CIDEA gene (18p11.12) is 23.22 kb in length with
57 five exons and four introns. It was identified by virtue of its
58 sequence homology to the N-terminal region of the apop-
59 totic DNA fragmentation factor Dff40/CAD and Dff45/
60 ICAD [6]. CIDEA protein is a member of the cell death-
61 inducing DNA fragmentation factor alpha-like effector
62 (CIDE) protein family. CIDEA is highly expressed in
63 brown adipose tissue (BAT) of rodents and white adipose
64 tissue (WAT) of humans, and is associated with the
65 development of obesity in both rodents [7] and humans [8].
66 CIDEA-null mice show lean phenotypes with increased
67 metabolic rate and lipolysis in BAT, and are resistant to
68 diet-induced obesity and diabetes mellitus [7]. In humans,
69 CIDEA expression is associated with a decrease in body
70 mass index (BMI), waist measurement, waist-to-hip ratio
71 (WHR) and basal metabolic rate [8]. It has also been
72 suggested that CIDEA expression may cross-talk with
73 tumor necrosis factor-a (TNF-a). TNF-a down-regulates
74 CIDEA expression and at the same time stimulates basal
75 lipolysis in human fat cells [9].
76 Association studies on CIDEA gene focused on the
77 V115F (rs11545881) single nucleotide polymorphism
78 (SNP), which is a non-synonymous SNP in exon 4 that
79 results in an amino acid substitution (V115F). A study
80 showed that the V115F polymorphism was associated with
81 BMI both in males (P = 0.023) and females (P = 0.021),
82 and G allele was a risk allele (OR 1.32, 95 % CI
83 1.03–1.69) in a Swedish population [10]. However, our
84 previous research in both Japanese [11] and Chinese pop-
85 ulations [12] have shown that the T allele may serve as a
86 risk factor for metabolic syndrome and its related
87 phenotypes.
88 In this study, we genotyped V115F (rs11545881) in
89 another Chinese sample to validate this risk allele for obesity,
90 and further selected another four tag-SNPs in the CIDEA
91 gene (rs4796955/SNP1, rs8092502/SNP2, rs12962340/
92 SNP3, and rs7230480/SNP4). This was done to investigate a
93 possible interaction between the effects of SNPs and hap-
94 lotypes of the CIDEA gene on obesity in Han Chinese.
95 Materials and methods
96 Subjects
97 This present study was a part of the National High Tech-
98 nology Research and Development Program-863 of China,
99 a population-based cross-sectional survey on relative risk
100 factors of chronic non-communicable diseases (NCD) in
101 the Chinese population during a 2-year period of
1022007–2008. We selected 309 obese and 433 controls from
103the 3,000 participants of this nation-wide study and mat-
104ched on age, gender and residence. An individual was
105defined as being obese if they had a BMI of 28 kg/m2 or
106more, according to the recommended standard by the
107Cooperative Meta-analysis Group of Working Group on
108Obesity in China [13]. We excluded from this study indi-
109viduals with the following: (1) physician-diagnosed dia-
110betes mellitus, coronary heart disease, myocardial
111infarction, stroke, cancer, severe kidney or liver diseases;
112(2) infectious diseases; (3) secondary obesity caused by
113other reasons; and (4) Cushing Syndrome.
114All of the participants signed informed consents before
115participating in this study, with approval been granted by
116the Ethical Committee, Capital Medical University, Bei-
117jing, China.
118Measurement of anthropometric parameters
119Following an interview by questionnaire, which covered
120demographic characteristics, residential history, socioeco-
121nomic status, personal behavior and medical history, all
122participants were asked to fast overnight before having a
123physical examination. Body weight, height, waist circum-
124ference (WC), hip circumference (HC), systolic blood
125pressure (SBP) and diastolic blood pressure (DBP) were
126measured by well-trained community doctors. Each mea-
127surement was performed three times and the average value
128was calculated as a final reading. Height and weight were
129measured to the nearest 0.1 kg and 0.1 cm respectively,
130with participants wearing light indoor clothing without
131shoes. BMI was calculated as weight in kilograms divided
132by height in meters squared (kg/m2). After inhalation and
133exhalation, WC was obtained at the midpoint between the
134lowest rib and the iliac crest to the nearest 0.1 cm, while
135the subject stood upright, with arms hanging freely and feet
136together. HC was measured over nonrestrictive underwear
137or light-weight shorts at the level of the maximum exten-
138sion of the buttocks in a horizontal level, without com-
139pressing the skin. WHR was calculated as WC divided by
140HC. Blood pressure was measured by mercury sphygmo-
141manometer on the right arm of the participant in a com-
142fortable sitting position after at least a 15 min rest.
143Finger capillary blood collection and DNA preparation
144Finger capillary blood was collected in the morning after
145an overnight fasting, and stored on 903 specimen collection
146paper (Kent, UK). The saver card has a sample collection
147area of five 1.3 cm circles with each circle holding
14875–80 lL of sample. Paper samples were air dried over-
149night, then individually placed in plastic bags with desic-
150cants and stored at -20 C.
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151 Whole-genome DNA was extracted by the Chelex-100
152 extraction method [14]. Firstly, a piece of 3 mm 9 3 mm
153 dried blood stain was cut down and put into a 1.5 mL
154 centrifuge tube. Then 1 mL ddH2O was added, the tube
155 was shaken for 10 s and placed at room temperature for
156 half an hour. After centrifugation for 3 min at 12,5009g,
157 the majority of the supernatant liquid was removed and
158 200 lL of freshly prepared 5 % (w/v) Chelex-100 was
159 added into the tube. The sample was mixed for 10 s and
160 followed by centrifugation for 3 min at 12,5009g again.
161 The sample was then incubated at 56 C for 30 min, fol-
162 lowed by 100 C for 8 min. Finally, centrifugation for
163 3 min at 13,0009g was performed. The supernatant liquid
164 containing DNA was stored at 4 C for amplification.
165 Tag-SNP selection
166 We downloaded Han Chinese population SNP data from
167 the database of the international HapMap Project (HapMap
168 Data Rel 24/phase II Nov08, on NVBI B36 assembly,
169 dbSNP b126). Using Haploview 4.0 software, we selected
170 five tag-SNPs of the CIDEA gene (SNP/V115F:
171 rs11545881, SNP1: rs4796955, SNP2: rs8092502, SNP3:
172 rs12962340, and SNP4: rs7230480) which had a minor
173 allele frequency (MAF) C5 % in Han Beijing Chinese.
174 Among the SNPs whose r2 C0.8, we selected the one with
175 highest MAF for genotyping. Figure 1a shows the detailed
176 information of the selected tag-SNPs of the CIDEA gene.
177 SNP genotyping
178 A combined approach utilizing nested polymerase chain
179 reaction (PCR) and pyrosequencing technology (PSQ
180 96MA, BIOTAGE, Sweden) was used for V115F
181genotyping. The nested PCR primers were designed as fol-
182lowed: the outside primers were 50-CTGGCATAAGAGCA
183GAGTG-30 (forward) and 50-GAGCCTGTGGGATAAG
184AGT-30 (reverse), and the inner primers were 50-GGT
185TAGGAAGGCTCCTGA-30 (forward) and 50-GATGTCG
186TAGGACACGGAGTA-30 (reverse). The pyrosequencing
187primers were 50-CAGGGCAGCCAGCAC-30. The first-
188stage PCR was executed in a 20 lL volume containing 2 lL
189109 PCR buffer (including MgCl2), 2 lL dNTPs (2.5 mM),
1900.2 lL forward primer(20 lM), 0.2 lL reverse pri-
191mer(20 lM), 4 lL genomic DNA (25 ng/lL), 0.08 lL Taq
192polymerase (5 U/lL, Takara, Japan), and 11.52 lL deion-
193ized H2O. The second-stage PCR was executed in a 55 lL
194volume containing 5.5 lL 109 PCR buffer (including
195MgCl2), 5.5 lL dNTPs (2.5 mM), 0.55 lL forward primer
196(20 lM), 0.55 lL reverse primer (20 lM), 3 lL DNA (the
197production of the first-stage PCR), 0.22 lL Taq polymerase
198(5 U/lL, Takara, Japan) and 39.68 lL deionizedH2O. PCRs
199were initiated by denaturation at 95 C for 5 min, followed
200by 35 cycles of; 30 s at 94 C, 30 s at 57 C, and 60 s at
20172 C, with the PCR products prolonged for 10 min at 72 C
202in the final cycle and finally held at 4 C.
203The genotyping of the other four tag-SNPs (SNP1:
204rs4796955, SNP2: rs8092502, SNP3: rs12962340 and
205SNP4: rs7230480) was performed using the sequenom
206matrix-assisted laser desorption/ionization time-of-flight
207(MALDI-TOF) mass spectrometry (MS) iPLEX platform
208[15]. This technique is a high-throughput MS method for
209detecting SNPs. According to the manufacturers’ instruc-
210tions, the whole process includes: multiplex PCR amplifi-
211cation, shrimp alkaline phosphatase treatment, iPLEX
212primer extension, clean resin, MALDI-TOF MS analysis
213and data analysis [16, 17].
214We randomly selected 30 samples from the participants
215to validate the genotyping results of all the five SNPs using
216another genotyping method, i.e., Sanger dideoxy method to
217confirm the identity.
218Statistical analysis
219Each polymorphism was evaluated for Hardy–Weinberg
220equilibrium by online software (http://ihg2.helmholtz-
221muenchen.de/cgi-bin/hw/hwa1.pl). P C 0.01 was consid-
222ered to obey the Hardy–Weinberg equilibrium. The dis-
223tributions of allelic and genotypic frequencies were
224analyzed using v2 test. The single locus association
225between a polymorphism and obesity was estimated by
226multiple logistic regression analysis, with age and gender
227adjusted. For continuous variables with normal distribu-
228tion, we used ANOVA to detect the difference of distri-
229bution between the different genotypes. The variables
230which were non-normal distributions were analyzed via
231rank sum test. The statistical analyses were carried out
Fig. 1 a The location of the tag-SNPs in the CIDEA gene. The exons
were indicated by black boxes. b LD plot among five tag-SNPs of
CIDEA gene
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232 using SPSS version 19.0 for Windows (SPSS Inc., Chi-
233 cago, IL, USA). The frequencies of the haplotypes and
234 association analyses were completed by Haploview soft-
235 ware (version 4.0; Mark Daly’s Laboratory, Broad Insti-
236 tute; http://sourceforge.net/projects/haploview/) [18]. We
237 analyzed the presence of interactions associated with
238 obesity susceptibility between the tag-SNPs by multifactor
239 dimensionality reduction method (MDR) (version 1.1.0;
240 Computational Genetics Laboratory, Dartmouth Medical
241 School, Lebanon, NH; www.epistasis.org) and logistic
242 regression. The MDR method is nonparametric and model-
243 free, which is directly applicable to case–control studies to
244 detect the interaction between gene–gene and gene–envi-
245 ronment. The best MDR model is determined to have a
246 P value\0.05, a maximum testing accuracy and a high
247 cross-validation consistency (CVC) [19]. Probability val-
248 ues presented were for two-tailed tests and P\ 0.05 was
249 considered statistically significant.
250 Results
251 V115F polymorphism of CIDEA gene and obesity
252 V115F (G/T) was genotyped in 742 participants (309 obese
253 vs. 433 controls), with the basal demographic and clinical
254 characteristics of these participants summarized in
255 Table 1. The obese group had significantly higher levels of
256 BMI, SBP, DBP, WC, HC and WHR compared to the
257 control group. No significant differences were found in age
258 and gender among the two groups (Table 1).
259 V115F genotypic frequencies for the GG, GT and TT
260 were 19.54, 59.70, and 20.75 %, respectively. The allelic
261 frequencies of G and T alleles were 49.39 and 50.61 %,
262 respectively. The genotypic distribution of the V115F
263 followed Hardy–Weinberg equilibrium in the controls
264 (P = 0.011). The frequency of the TT genotype was sig-
265 nificantly higher in the obese group compared to the con-
266 trol group (23.62 vs. 18.71 %, P\ 0.001) (Table 2).
267 Multiple logistic regression analysis (age and gender
268 adjusted) identified that participants with the TT genotype
269 were 2.84-fold at risk (95 % CI 1.73–4.66, P\ 0.001) and
270 those with the GT genotype were 2.63-fold at risk
271 (95 % CI 1.72–4.01, P\ 0.001) for obesity when com-
272 pared to those with the GG genotype. Meanwhile, v2
273 analysis results showed that participants with the T allele
274 were 1.46-fold (95 % CI 1.19–1.80, P\ 0.001) at risk for
275 obesity when compared to those with the G allele.
276 In genotypic model (GG vs.GT vs.TT), we found that
277 the average BMI, WC, HC and WHR measurements were
278 highest in patients with the TT genotype followed by GT
279 and GG. In the dominant model (TT vs. TG ? GG), we
280 found that these obesity related levels were significantly T
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281 higher in TT group than those in GG ? GT group (BMI,
282 P\ 0.001; SBP, P\ 0.001; DBP, P\ 0.001; WC,
283 P = 0.012; HC,P = 0.042;WHR,P\ 0.001, respectively)
284 (Table 1). In the recessive model (GG vs. GT ? TT), the
285differences of these levels were significantly higher in
286GT ? TT group compared to the GG group as expected
287(BMI, P\ 0.001; SBP, P\ 0.001; DBP, P\ 0.001; WC,
288P\ 0.001; HC, P = 0.005, WHR, P\ 0.001, respectively)
Table 2 Multiple logistic regression analysis of associations between the CIDEA genotypes and obesity
SNPs Polymorphism Controla Obesitya P valueb OR 95 % CI
SNP1 Genotype 0.006*
GG 46 (26.59) 68 (43.31) 0.027* 2.19 1.09–4.38
GT 99 (57.23) 70 (44.59) 0.903 1.04 0.54–2.02
TT 28 (16.18) 19 (12.10) – 1.00 –
Allele
G 191 (55.20) 206 (65.61) 0.006D* 1.55 1.13–2.12
T 155 (44.80) 108 (34.39)
SNP2 Genotype 0.005*
CC 3 (1.73) 13 (8.39) 0.025* 4.37 1.21–15.80
TC 62 (35.84) 36 (23.23) 0.035* 0.59 0.04–0.96
TT 108 (62.43) 106 (68.39) – 1.00 –
Allele
C 68 (19.65) 62 (20.00) 0.911D 1.02 0.70–1.50
T 278 (80.35) 248 (80.00)
SNP3 Genotype 0.367
TT 91 (81.98) 76 (88.37) 0.811 1.16 0.35–3.80
TA 13 (11.71) 5 (5.81) 0.424 0.53 0.11–2.50
AA 7 (6.31) 5 (5.81) – 1.00 –
Allele
T 195 (87.84) 157 (91.28) 0.272D 1.45 0.75–2.82
A 27 (12.16) 15 (8.72)
SNP4 Genotype 0.968
CC 128 (73.99) 117 (74.52) 0.799 1.22 0.26–5.67
CT 41 (23.7) 37 (23.57) 0.810 1.21 0.25–5.86
TT 4 (2.31) 3 (1.91) – 1.00 –
Allele
C 297 (85.84) 271 (86.31) 0.862D 1.04 0.670–1.62
T 49 (14.16) 43 (13.69)
V115F Genotype \0.001*
TT 81 (18.71) 73 (23.62) \0.001* 2.84 1.73–4.66
GT 242 (55.89) 201 (65.05) \0.001* 2.63 1.72–4.01
GG 110 (25.40) 35 (11.33) – 1.00 –
Allele
T 404 (46.65) 347 (56.15) \0.001D* 1.46 1.19–1.80
G 462 (53.35) 271 (43.85)
Combined genotypes \0.001*
0-risk 106 (61.27) 61 (38.85) – 1.00 –
1-risk 56 (32.37) 72 (45.68) 0.001* 2.23 1.40–3.58
2-risk 11 (63.58) 24 (15.29) 0.001* 3.79 1.74–8.28
OR odd ratio, 95 % CI 95 % confidence interval
* P\ 0.05
a Numbers are frequencies and percentage
b P value was calculated by v2 test (D) or multiple logistic regression (age and sex adjusted)
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289 (Table 1). The distribution of the two genotype frequencies
290 were significantly different between the obese and controls
291 (P\ 0.001).
292 Association between the other four tag-SNPs
293 and obesity
294 We genotyped another four selected CIDEA tag-SNPs
295 (SNP1 G/T, SNP2 T/C, SNP3 T/A, SNP4 C/T) in 330
296 participants (obese/controls = 157/173). Distributions of
297 the genotypes and alleles of the four SNPs are listed in
298 Table 2. Analysis showed that the controls were in Hardy–
299 Weinberg equilibrium at SNP1 (P = 0.039), SNP2
300 (P = 0.076) and SNP4 (P = 0.740), while the genotypic
301 distribution of SNP3 did not follow Hardy–Weinberg
302 equilibrium (P\ 0.001), so SNP3 was excluded from
303 further analysis. The MAF of these SNPs (SNP1T, SNP2C
304 and SNP4T) were 44.80, 19.65 and 14.17 % in controls,
305 respectively (Table 2). These were consistent with the
306 MAF of Han Chinese in Beijing, China (http://www.ncbi.
307 nlm.nih.gov/pubmed). Multiple logistic regression analysis
308 (adjusted by age and gender) indicated that both SNP1 and
309 SNP2 polymorphisms were significantly associated with
310 obesity (P = 0.006 and 0.005, respectively) (Table 2).
311 SNP1/GG and SNP2/CC genotypes were more frequent in
312 the obese group compared to the control group (P = 0.027,
313 0.025, respectively).
314 The analysis results of SNP1 showed overall that WC and
315 BMI levels in the GG genotype (WC = 90.31 ± 10.91 cm;
316 BMI = 27.08 ± 4.24 kg/m2) were significantly higher
317 compared to any other two genotypes (GT: WC = 86.06 ±
318 12.00 cm, P = 0.030; BMI = 25.45 ± 4.45 kg/m2, P =
319 0.030; TT: WC = 85.94 ± 11.36 cm, P = 0.002; BMI =
320 25.41 ± 4.43 kg/m2, P = 0.028), suggesting that partici-
321 pants with the GG genotype were more susceptible to
322 obesity. Multiple logistic regression (adjusted for age and
323 gender) analysis revealed that when compared with the TT
324 genotype, participants carrying the GG genotype had a 2.19-
325 fold (95 % CI 1.09–4.38, P = 0.027) risk of obesity, and
326when compared with the T allele, participants with the G
327allele had a 1.55-fold (95 % CI 1.13–2.12, P = 0.006) risk
328of obesity. All of these results indicated that the variant G
329allele of SNP1 was the risk allele of obesity.
330The analysis results of SNP2 showed thatWC levels were
331higher based on genotypes of CT (84.55 ± 11.62 cm)\TT
332(88.31 ± 11.32 cm)\CC (92.75 ± 11.70 cm), and there
333was a statistically significant difference between the three
334genotypes (P = 0.005). Logistic regression analysis of
335SNP2 showed that when compared with the TT genotype,
336participants with the CC genotype had a 4.37-fold (95 % CI
3371.21–15.80, P = 0.025) risk, while the CT genotype was
338lower with a 0.59-fold (95 % CI 0.04–0.96, P = 0.035) risk
339of obesity. No significant difference was detected in the BMI
340according to the genotypes.
341Haplotypes analysis of the selected tag-SNPs of CIDEA
342gene
343When we combined the four tag-SNPs and inferred haplo-
344types using Haploview 4.0 software, ten possible haplotypes
345were derived from the observed genotypes (SNP1/SNP2/
346V115F/SNP4) (Fig. 1b). Six haplotypes with frequencies
347above 5 % were haplotype 1 (H1)-GTTC (33.5 %), H2-
348GTGC (20.7 %), H3-TCGC (9.4 %), H4-TCTC (8.9 %),
349H5-TTTC (6.7 %) andH6-TTGC (6.0 %) (Table 3). H1was
350more common in the obese participants (37.55 %) compared
351to the controls (29.91 %,P = 0.039),whileH6was common
352in the controls (7.92 %) compared to the obese (3.98 %,
353P = 0.034). The risk of obesity was significantly increased
354among the participants carrying haplotype H1 (OR 1.41,
35595 % CI 1.02–1.95), and decreased among participants with
356haplotype H6 (OR 0.48, 95 % CI 0.24–0.96).
357Interaction analysis of CIDEA gene tag-SNPs
358on obesity
359Assuming a combined model (i.e. homozygous risk geno-
360types vs. the combining group of the other two genotypes),
Table 3 Frequencies of the haplotypes based on the tag-SNPs in obese and controls
Haplotypes Genotype Freq. Obesity Control v2 value P value OR 95 % CI
SNP1 SNP2 V115F SNP4 n (%) n (%)
H1 G T T C 0.335 117.9 (37.55) 103.5 (29.91) 4.28 0.039* 1.41 1.02–1.95
H2 G T G C 0.207 65.9 (20.99) 70.8 (20.46) 0.03 0.869 1.03 0.71–1.51
H3 T C G C 0.094 26.4 (8.41) 35.4 (10.23) 0.64 0.425 0.81 0.48–1.37
H4 T C T C 0.089 31.1 (9.90) 27.8 (8.03) 0.71 0.401 1.26 0.74–2.15
H5 T T T C 0.067 15.5 (4.94) 28.5 (8.24) 2.9 0.088 0.58 0.31–1.10
H6 T T G C 0.060 12.5 (3.98) 27.4 (7.92) 4.51 0.034* 0.48 0.24–0.96
OR odd ratio, 95 % CI 95 % confidence interval
* P\ 0.05
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361 we did combined analyses for the three SNPs which were
362 significantly associated with obesity in the previous single
363 locus analysis; SNP1 (GG vs. GT ? TT); SNP2 (CC vs.
364 CT ? TT); V115F (TT vs. GT ? GG). Compared with
365 those carrying genotypes of SNP1/GT ? TT, SNP2/
366 CT ? TT and V115F/GT ? GG, participants carrying
367 only one of the three homozygous risk genotypes (SNP1/
368 GG or SNP2/CC or V115F/TT) were associated with a
369 2.23-fold (95 % CI 1.40–3.58, P = 0.001) increased risk
370 to obesity, while the risk was statistically increased to 3.79-
371 fold (95 % CI 1.74–8.28, P = 0.001) among individuals
372 carrying two of the three homozygous risk genotypes
373 (SNP1/GG*SNP2/CC, SNP2/CC*V115F/TT, SNP1/
374 GG*V115F/TT) (Table 2). Furthermore, we found that
375 among the participants with two homozygous risk geno-
376 types, 91.43 % of them were carrying both genotypes of
377 SNP1/GG and V115F/TT. The other 8.57 % were carrying
378 both genotypes of SNP2/CC and V115F/TT.
379 In logistic regression models (adjusted by age and
380 gender), the interaction between SNP1 and V115F was
381 significantly associated with the susceptibility of obesity
382 (P = 0.012). The interaction showed that individuals with
383 both genotypes of SNP1/GG and V115F/TT were associ-
384 ated with 2.66-fold (95 % CI 1.22–5.80, P = 0.012) risk of
385 obesity, compared with the others. The risk was increased
386 to 3.21-fold when compared to participants with both
387 genotypes of SNP1/TT and V115F/GG (95 % CI 1.33–
388 7.73, P = 0.009).
389 MDR analysis was also used to detect the interaction
390 between the four tag-SNPs (V115F, SNP1, SNP2 and
391 SNP4). Table 4 summarizes the best interaction models. In
392 one-factor model, SNP2 was the best attribute for pre-
393 dicting obesity (testing accuracy = 54.58 %; CVC = 9/
394 10, P = 0.377). SNP1 and SNP2 was the best two-factor
395 model (testing accuracy = 53.56 %, CVC = 7/10,
396 P = 0.172). However, by following the best model selec-
397 ted principle, the best model was determined to be a four-
398 loci site model, which includes the polymorphisms of
399 SNP1, SNP2, V115F and SNP4, with a maximum testing
400 accuracy to 59.32 % and a perfect CVC of 10/10
401 (P = 0.011). Thus, the interaction dendrogram (Fig. 2)
402 showed that these four SNPs linked by green lines were on
403 the same branch, suggesting a synergistic interaction effect
404 on modulating the risk of obesity.
405Discussion
406In this study, we genotyped five tag-SNPs in the CIDEA
407gene and investigated their associations with the risk of
408obesity in a Han Chinese population. We found that SNP1-
409rs4796955/GG genotype, SNP2-rs8092502/CC genotype,
410V115F-rs11545881/TT genotype and haplotype GTTC
411were associated with an increased risk of obesity
412(P\ 0.05). The MDR analysis identified a significant four-
413factor interaction model including SNP1, SNP2, V115F
414and SNP4, suggesting that there was an interaction between
415the four SNPs. The logistic regression analysis (adjusted by
416age and gender) showed the interaction between SNP1 and
417V115F was significantly associated with the susceptibility
418of obesity.
419Both human and mouse models show that CIDEA pro-
420tein is emerging as an important regulator of the lipid
421metabolic pathway, and it plays important roles in lipid
422storage, lipid droplet format, lipolysis and the development
423of metabolic disorders such as obesity, diabetes mellitus,
424hepatic steatosis and cardiovascular diseases [7–9]. Mice
425with a deficiency in CIDEA were resistant to high-fat diet-
426induced obesity and diabetes mellitus with an increased
427metabolic rate, lipolysis in BAT and core body temperature
428when subjected to cold treatment, suggesting that CIDEA is
429important in energy expenditure in adipose tissues [7].
430Their lean phenotype seems to be due to a loss of CIDEA
431protein direct suppression of uncoupling protein 1 (UCP1)
432activity in BAT [20]. However, there are some striking
433discrepancies between human and rodent CIDEA protein
434expression patterns. CIDEA protein is highly expression in
435BAT of rodent but in WAT of humans [8]. In contrast with
436the mouse model, CIDEA protein expression in humans is
437inversely associated with BMI, WC, WHR and basal meta-
438bolic rate. Some studies have reported that CIDEA protein
Table 4 Summary of the MDR
interaction models
* P\ 0.05
Model Training bal.
acc. (%)
Testing bal.
acc. (%)
Sign test (P) CV consistency
SNP2 57.49 54.58 6 (0.377) 9/10
SNP1SNP2 60.23 53.56 7 (0.172) 7/10
SNP1SNP2V115 63.23 54.75 9 (0.011*) 7/10
SNP1SNP2V115SNP4 65.91 59.32 9 (0.011*) 10/10
Fig. 2 Interaction dendrogram. The different color connections show
the degree of interaction from synergy (red) to redundancy (blue)
AQ1
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439 expression was decreased two-fold in obese humans and
440 normalized after weight reduction [9]. A study in 40 obese
441 women showed that CIDEA gene expression is significantly
442 up-regulated as a result of the energy-restricted diets inter-
443 vention [21]. In contrast to the mechanism in mice, a study
444 found that there is a cross-talk betweenCIDEA and TNF-a in
445 human adipose tissue [9], and this has consequences for
446 lipolysis. CIDEA decreases the availability of TNF-a by
447 inhibiting cytokine secretion predominately through post-
448 transcriptional mechanisms, which in turn counteracts the
449 ability of TNF-a to stimulate lipolysis. TNF-a down-regu-
450 lates the expression of CIDEA through signaling via c-Jun
451 NH2-terminal kinase (JNK), which in turn increases the
452 availability of TNF-a and thereby lipolytic stimulation [9].
453 In a recent energy restriction intervention study [8], a sig-
454 nificant inverse correlation has been found between UCP1
455 and CIDEA expression levels, indicating a possible interac-
456 tion between CIDEA and UCP1 in humans. CIDEA is also
457 associated with insulin sensitivity in humans [22]. Recently,
458 a study found that starvation-induced apoptosis in adipocytes
459 is significantly inhibited when insulin decreased CIDEA
460 mRNA expression levels, suggesting that CIDEA is a novel
461 gene regulated by insulin in human adipocytes and that it
462 may play a key role in obesity [23].
463 CIDEA polymorphisms have been reported to be asso-
464 ciated with human obesity in Swedish, Japanese and Chi-
465 nese populations. In this study, the G allele frequency of
466 V115F was 49.39 %, which was lower than that previously
467 reported in the Chinese (55.25 %) population and higher
468 than reported in the Japanese (48.90 %) population [11,
469 12]. Multiple logistical regression results showed that
470 participants with the TT genotype had a 2.84-fold
471 (95 % CI 1.73–4.66, P\ 0.001) risk for obesity compared
472 to those with the GG genotype. There was a trend that all
473 the index levels of obesity related phenotypes in the par-
474 ticipants were higher in the TT genotype group compared
475 to the GG genotype groups (TT[GT[GG). Both
476 genetic and continuous variable analyses indicated that the
477 T allele of V115F SNP was a risk factor for obesity in
478 Chinese. This result is consistent with our previous studies
479 in both Japanese [11] and Chinese studies [12], but con-
480 flicts with the Swedish study [10]. This result could be due
481 to the so-called ‘‘flip-flop’’ phenomenon, where, within
482 differing ethnic groups, disease marker associations with
483 reversed risk alleles are found [24, 25].
484 The possible impact of amino acid substitution of V115F
485 on the structure and function of CIDEA protein would be
486 benign based on the POLYPHEN analysis [12]. We con-
487 sidered that there might be some other causal variants at this
488 locus, whose polymorphism, interaction or linkage disequi-
489 librium could contribute to obesity; therefore, we further
490 genotyped another four tag-SNPs of the CIDEA gene to test
491 our hypotheses.
492In single locus analysis, we found that two other new
493SNPs (SNP1 and SNP2) were associated with obesity.
494Subjects with SNP1/GG and SNP2/CC genotypes had
495higher levels of WC, and were associated with 2.19-fold
496and 4.37-fold increased susceptibility to obesity when
497compared with other genotype groups. Both SNP1 and
498SNP2 were intronic polymorphisms whose functions were
499not known. However, there have been reports about the
500association between intronic polymorphisms and different
501diseases [26–28]. For example, it was reported that up to
50240 % of transcription factor binding sites are located within
503introns. The exact molecular mechanisms of how the SNP1
504and SNP2 variants affect obesity are unknown and require
505further investigation.
506In haplotype analysis, we found that haplotype GTTC had
5071.41-fold risk, while haplotypeTTGCwas a protective factor
508for obesity. Not surprisingly, the differences between hap-
509lotypeGTTC andTTGCwere associatedwith SNP1G/T and
510V115F G/T alleles. Both of these risk alleles (SNP1/G and
511V115F/T) contributed to the risk haplotype of GTTC, while
512the protective alleles (SNP1/T and V115F/G) contributed to
513the haplotype TTGC. Logistic regression analysis found that
514there was a statistically significant interaction between these
515two SNPs, and participants with both SNP1/GG and V115F/
516TT genotypes had 2.66-fold risk of developing obesity.
517There is significant evidence showing that complex dis-
518eases are induced by gene–gene, gene–environmental and
519gene–environmental–behavior interactions. It is conceivable
520that obesity is the result of interactions between multiple
521genetic variations. In this study, the combined results of the
522nonparametric MDR approach and the parametric logistic
523analysis (adjusted by age and gender) indicated that the
524interaction betweenSNP1/GGandV115F/TT could increase
525the susceptibility of obesity occurring. Although our data
526cannot explain the biological mechanism, the result suggests
527that an interaction model could provide guidance to experi-
528mental studies on the metabolic pathway of obesity.
529For this population screening study, 903 specimen col-
530lection paper was used to collect finger blood, which causes
531less discomfort to the subjects. The dried blood spots needed
532minimal storage space, caused little biohazard risk and were
533convenient for transportation [14]. The method also had the
534disadvantage of not having fresh blood samples for blood
535biochemical analyses such as triglyceride, total cholesterol,
536high density lipoprotein, which are associated with lipolysis.
537There were other limitations in our study. Firstly, the con-
538founding factors such as diet, physical activity and environ-
539ment were not considered. Secondly, all the associations
540offered in this study were a population-genetics based
541approach supported by statistical analyses, and therefore the
542explanation of the biological mechanism of obesity needs
543further investigation. Furthermore, recent interesting findings
544collectively highlight the complicated metabolite profiles in
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545 obesity at omics level, inspiring that post-genomics comple-
546 mentary approaches in obesity research are needed [29].
547 In conclusion, this is the first attempt to haplotype four
548 SNPs in the CIDEA gene in a Han Chinese population, and
549 we found that SNP1-rs4796955, SNP2-rs8092502, V115F-
550 rs11545881, haplotype GTTC and haplotype TTGC were
551 associated with the susceptibility of obesity. The strong
552 interaction between SNP1 and V115F could play a joint
553 role in the development of obesity. Further studies with
554 ethnically diverse populations and functional evaluation
555 are warranted to confirm our findings.
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